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EFFECTS OF DEPHOSPHORYLATION IN 7E MUTANTS OF NPR-A 
Bridget Wall and Brian Walter* 
Biology Department, Illinois Wesleyan University 
Natriuretic peptides (designated ANP, BNP, and CNP) are hormones and paracrine factors which 
regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat 
metabolism and long bone growth. When bound to natriuretic peptide receptors, they allow for 
the production of cGMP (cyclic guanosine monophosphate), a secondary messenger which 
allows for the production of proteins from the cell .  These receptors are designated NPR-A/GC­
A and NPR-B/GC-B. Both are guanylyl cyclases (enzymes that synthesize cGMP). The focus 
of this research is to further examine the involvement of dephosphorylation in the desensitization 
of natriuretic peptide receptors. Previously, phosphorylation sites on the guanylyl cy1case 
domain have been mutated to express glutamate, an amino acid with a charge of - 1  (the charge of 
a phosphate is -2). Therefore, the glutamate is mimicking the charge on the phosphoryl at residue 
present when the receptor is phosphorylated. 
Ergo, these NPR-A mutants (hereafter referred to as 7E mutants) are constitutively 
phosphorylated and always active. Within the current model, there should be a significant 
difference in cGMP production when stimulated with natriuretic peptides. By continuing 
previous studies geared toward a better understanding of phosphorylation in these receptors, 
members of the field of pharmocology will be able to develop a drug that will either semi­
permanently dephosphorylate or phosphorylate natriuretic peptide receptors in an effort to treat 
heart disease and hypertension. 
